Early research (Phase 1)Study completedNCT01054300
What this trial is testing
Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)
Who this might be right for
Diabetes Mellitus, Type 2Adult
Merck Sharp & Dohme LLC 52